TapewireFind a company

person · Reporting owner

Gracey Craig

Disclosed activity across 2 companies

Tapewire entity
2370
SEC CIK
0002021724

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Omada Health, Inc.OMDA · Entity 2364Chief Accounting OfficerSeptember 09, 2026September 11, 2026
Vacasa, Inc.VCSA · Entity 80158Chief Accounting OfficerJuly 01, 2024July 06, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Omada Health, Inc.

Report date September 09, 2026 · Filed September 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect14,412 Reported balance After 2026-09-09 transaction · row 1
1 source row

Row 1 · 2026-09-09 · Sale · Disposed 644 · Balance 14,412

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Vacasa, Inc.

Report date July 01, 2024 · Filed July 06, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect21,242 Reported balance After 2024-07-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2024-07-01 · Grant · Acquired 16,051 · Balance 21,242

F1: Represents an award of restricted stock units, or RSUs, with 1/3 vesting annually beginning on February 20, 2024. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units, or RSUs, with 1/3 vesting annually beginning on February 20, 2024. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 09, 2026 Filed Sep 11, 2026 20:45 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 644 $21.73 $13,995.15
Disclosure

SEC source: 0001610717-26-000413 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,412

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 22:23 UTC Omada Health, Inc. OMDA · Entity 2364 Tax withholdingCommon Stock 385 $22.84 $8,793.40
Disclosure

SEC source: 0001610717-26-000399 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,056

Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:46 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 1,042 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000355 · form4.xml · derivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,292

Underlying: Common Stock · 1,042 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:46 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 1,042 $25.00 $26,050.00
Disclosure

SEC source: 0001610717-26-000355 · form4.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:46 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 1,042 $6.57 $6,845.94
Disclosure

SEC source: 0001610717-26-000355 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,483

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
July 13, 2026 Filed Jul 15, 2026 20:33 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 1,041 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000338 · form4.xml · derivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,334

Underlying: Common Stock · 1,041 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
July 13, 2026 Filed Jul 15, 2026 20:33 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 1,041 $24.00 $24,984.00
Disclosure

SEC source: 0001610717-26-000338 · form4.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
July 13, 2026 Filed Jul 15, 2026 20:33 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 1,041 $6.57 $6,839.37
Disclosure

SEC source: 0001610717-26-000338 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2026 Filed Jul 3, 2026 00:04 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 637 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000320 · form4.xml · derivative · entry 6

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,375

Underlying: Common Stock · 637 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
July 01, 2026 Filed Jul 3, 2026 00:04 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 637 $23.00 $14,651.00
Disclosure

SEC source: 0001610717-26-000320 · form4.xml · nonDerivative · entry 4

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
July 01, 2026 Filed Jul 3, 2026 00:04 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 637 $6.57 $4,185.09
Disclosure

SEC source: 0001610717-26-000320 · form4.xml · nonDerivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2026 Filed Jul 3, 2026 00:04 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 405 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000320 · form4.xml · derivative · entry 5

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,012

Underlying: Common Stock · 405 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
June 30, 2026 Filed Jul 3, 2026 00:04 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 405 $22.00 $8,910.00
Disclosure

SEC source: 0001610717-26-000320 · form4.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
June 30, 2026 Filed Jul 3, 2026 00:04 UTC Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 405 $6.57 $2,660.85
Disclosure

SEC source: 0001610717-26-000320 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 23:09 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,083 $21.00 $43,743.00
Disclosure

SEC source: 0001610717-26-000307 · form4.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 858

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
June 29, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 2,083 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000334 · form4a.xml · derivative · entry 6

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,417

Underlying: Common Stock · 2,083 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
June 29, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,083 $21.00 $43,743.00
Disclosure

SEC source: 0001610717-26-000334 · form4a.xml · nonDerivative · entry 4

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F1 · balance_after: This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 29, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 2,083 $6.57 $13,685.31
Disclosure

SEC source: 0001610717-26-000334 · form4a.xml · nonDerivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 23:09 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,084 $20.00 $41,680.00
Disclosure

SEC source: 0001610717-26-000307 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,941

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
June 26, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 2,084 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000334 · form4a.xml · derivative · entry 5

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 2,084 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
June 26, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,084 $20.00 $41,680.00
Disclosure

SEC source: 0001610717-26-000334 · form4a.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F1 · balance_after: This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 26, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 2,084 $6.57 $13,691.88
Disclosure

SEC source: 0001610717-26-000334 · form4a.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,525

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 24, 2026 Filed Jun 26, 2026 23:04 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,083 $19.01 $39,601.58
Disclosure

SEC source: 0001610717-26-000298 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,025

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 24, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 2,083 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000333 · form4a.xml · derivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,584

Underlying: Common Stock · 2,083 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
June 24, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,083 $19.01 $39,601.58
Disclosure

SEC source: 0001610717-26-000333 · form4a.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 24, 2026 Filed Jul 9, 2026 00:20 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 2,083 $6.57 $13,685.31
Disclosure

SEC source: 0001610717-26-000333 · form4a.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 20:17 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,083 $18.00 $37,494.00
Disclosure

SEC source: 0001610717-26-000291 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,108

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Read SEC document
June 22, 2026 Filed Jul 9, 2026 00:19 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 2,083 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000332 · form4a.xml · derivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,667

Underlying: Common Stock · 2,083 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
June 22, 2026 Filed Jul 9, 2026 00:19 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 2,083 $18.00 $37,494.00
Disclosure

SEC source: 0001610717-26-000332 · form4a.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F1 · balance_after: This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 22, 2026 Filed Jul 9, 2026 00:19 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 2,083 $6.57 $13,685.31
Disclosure

SEC source: 0001610717-26-000332 · form4a.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:55 UTC Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 6,894 $17.42 $120,123.12
Disclosure

SEC source: 0001610717-26-000225 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,191

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.04 to $17.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2026 Filed Jul 9, 2026 00:18 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionStock Option (Right to Buy) · Derivative 6,250 $0.00 Strike: $6.57 $0.00
Disclosure

SEC source: 0001610717-26-000331 · form4a.xml · derivative · entry 3

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Common Stock · 6,250 shares

Expires 2034-10-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/16/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
June 12, 2026 Filed Jul 9, 2026 00:18 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 SaleCommon Stock 6,894 $17.42 $120,123.12
Disclosure

SEC source: 0001610717-26-000331 · form4a.xml · nonDerivative · entry 2

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,441

F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $17.04 to $17.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: This Form 4/A restates in its entirety the original Form 4 filed on 6/16/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 12, 2026 Filed Jul 9, 2026 00:18 UTC Amendment Omada Health, Inc. OMDA · Entity 2364 Exercise / conversionCommon Stock 6,250 $6.57 $41,062.50
Disclosure

SEC source: 0001610717-26-000331 · form4a.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/16/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:18 UTC Omada Health, Inc. OMDA · Entity 2364 Tax withholdingCommon Stock 385 $18.38 $7,076.30
Disclosure

SEC source: 0001610717-26-000182 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,085

Read SEC document
March 05, 2026 Filed Mar 13, 2026 23:19 UTC Omada Health, Inc. OMDA · Entity 2364 GrantCommon Stock 16,470 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000100 · form4.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,470

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
July 01, 2024 Filed Jul 6, 2024 00:49 UTC Vacasa, Inc. VCSA · Entity 80158 GrantClass A Common Stock 16,051 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-026406 · ownership.xml · nonDerivative · entry 1

Gracey Craig · CIK 0002021724 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,242

F1 · balance_after: Represents an award of restricted stock units, or RSUs, with 1/3 vesting annually beginning on February 20, 2024. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.